ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,712Medicare Part D Prescriptions Filled, Including Refills

Rank: 455 out of 1456

$352K Total Retail Price of All Prescriptions

Rank: 636 out of 1456

323 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

17% of this provider’s 323 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 7,573 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
LISINOPRIL 343 302 1 3
PRAVASTATIN SODIUM 319 266 2 9
AMLODIPINE BESYLATE 300 270 3 1
SIMVASTATIN 291 239 4 2
LEVOTHYROXINE SODIUM 284 249 5 4
OMEPRAZOLE 265 251 6 5
FUROSEMIDE 213 188 7 7
ATENOLOL 206 159 8 18
HYDROCHLOROTHIAZIDE 185 158 9 10
HYDROCODONE-ACETAMINOPHEN 165 146 S3 10 6
GABAPENTIN 160 131 11 13
CARVEDILOL 150 133 12 20
METOPROLOL SUCCINATE 147 128 13 19
ATORVASTATIN CALCIUM 142 130 14 11
METFORMIN HCL ER 141 133 15 54
METFORMIN HCL 139 105 16 8
SERTRALINE HCL 136 120 17 25
WARFARIN SODIUM 113 102 18 21
PANTOPRAZOLE SODIUM 110 101 19 43
KLOR-CON M20 108 108 20 51
DOXAZOSIN MESYLATE 107 97 21 84
TRAMADOL HCL 103 87 22 17
METOPROLOL TARTRATE 95 78 23 12
LOSARTAN POTASSIUM 87 87 24 16
DONEPEZIL HCL 81 75 25 29
CRESTOR 77 76 26 26
GLIMEPIRIDE 72 67 27 33
TRICOR 70 52 28 92
ZOLPIDEM TARTRATE 70 55 28 14
FLUTICASONE PROPIONATE 69 62 30 28
NEXIUM 68 36 31 23
ALENDRONATE SODIUM 64 63 32 36
ALLOPURINOL 63 56 33 31
TRIAMTERENE-HCTZ 61 60 34 49
NAMENDA 61 61 34 38
RAMIPRIL 59 51 36 98
EVISTA 59 59 36 113
BENAZEPRIL HCL 54 54 38 57
DIGOXIN 53 53 39 62
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 45 40 24
ISOSORBIDE MONONITRATE ER 51 47 40 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 27, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.